The Development of Biocatalysis as a Tool for Drug Discovery.
Journal
Chimia
ISSN: 0009-4293
Titre abrégé: Chimia (Aarau)
Pays: Switzerland
ID NLM: 0373152
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
1
8
2020
Statut:
ppublish
Résumé
Enzymes are versatile biocatalysts capable of performing selective reactions. The advantages of enzymes in comparison to classical chemistry including chemical catalysts are the generally milder process conditions and avoidance of harmful reactants. Their high selectivity and specificity are especially beneficial for the enzymatic synthesis of new products with potential applications in drug research. Therefore, in the past decades, the utilization of isolated enzymes or whole-cell biocatalysts has spread through a growing number of biotechnological industries. The applications comprise the production of chiral building blocks for the pharmaceutical and fine chemical industry, the enzymatic synthesis of drug metabolites for testing of toxicity, function, biological activity, degradation and the production of biocatalytically modified natural products, which all play a role in drug discovery. Especially Oreste Ghisalba's contributions, which paved the way for the industrial use of enzymes, will be considered in this review.
Identifiants
pubmed: 32482213
doi: 10.2533/chimia.2020.368
doi:
Substances chimiques
Biological Products
0
Enzymes
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM